Skip to main content

Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo

Buy Article:

$51.00 plus tax (Refund Policy)


Treatment of vitiligo, despite significant advances made in the past few years, remains to be a challenge. Narrowband ultraviolet (NB-UVB) has emerged as an important therapeutic option for this condition. Objective:

To evaluate whether the combination of calcipotriene ointment and NB-UVB could enhance the efficacy of NB-UVB alone. Methods:

An open, bilateral comparison study was performed in 20 patients with symmetrical vitiligo between August 2001 and October 2002. All patients received NB-UVB three times per week. Calcipotriene ointment was applied to lesions on the left side of the body. Response was graded visually as significant (66–100% repigmentation), moderate (26–65%), mild (10–25%), and minimal (<10%). Results:

Seventeen patients (six females, 11 males) completed the study. Eight patients (8/17=47%) had significant repigmentation after 67–180 treatments, six patients (35%), one patient (6%), and two patients (12%) had moderate, mild, and minimal repigmentation after 40–160, 57, and 14–21 treatments, respectively. Nine of the 17 patients had an appreciably better improvement on the NB-UVB and calcipotriene side by 29–114 treatments. In six of these patients, differences were still observed at the end of the study period. No side effects were noted. Conclusion:

Combination therapy of topical calcipotriene and NB-UVB is a therapeutic option that could be considered in the management of patients with vitiligo.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: calcipotriene; narrowband UVB; vitiligo

Document Type: Research Article

Publication date: 2004-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more